Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more
The Stochastic Oscillator for VRTX moved into oversold territory on June 27, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for VRTX just turned positive on May 27, 2025. Looking at past instances where VRTX's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in of 353 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 262 cases where VRTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VRTX as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VRTX broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.868) is normal, around the industry mean (16.339). P/E Ratio (32.764) is within average values for comparable stocks, (58.407). Projected Growth (PEG Ratio) (2.740) is also within normal values, averaging (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (10.235) is also within normal values, averaging (253.057).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a company that discovers and develops novel, small molecule pharmaceuticals
Industry Biotechnology
A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with KRYS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then KRYS could also see price increases.
Ticker / NAME | Correlation To VRTX | 1D Price Change % | ||
---|---|---|---|---|
VRTX | 100% | -0.47% | ||
KRYS - VRTX | 49% Loosely correlated | -2.60% | ||
TECH - VRTX | 40% Loosely correlated | -1.82% | ||
SNDX - VRTX | 39% Loosely correlated | -3.12% | ||
IDYA - VRTX | 39% Loosely correlated | -4.04% | ||
RGNX - VRTX | 39% Loosely correlated | -4.11% | ||
More |